论文部分内容阅读
异基因造血干细胞移植(allogeneic hematopoi-etic stemcell transplantation,allo-HSCT)已成为治愈恶性血液病的重要手段。传统的allo-HSCT预处理方法以致死性的超大剂量化疗联合(或不联合)放疗进行预处理,摧毁患者的造血和免疫功能,最大限度地清除受体体内残存病灶,抑制宿主
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has become an important means to cure hematologic malignancies. Traditional allo-HSCT pretreatment method with fatal chemotherapy with large doses of chemotherapy combined with (or without) radiotherapy for pretreatment, to destroy the patient’s hematopoietic and immune function, to maximize the remnants of residual receptors in the body to eliminate the host